Better Target

Axcelead is the first integrated drug discovery solutions provider in the pharmaceutical industry in Japan, having inherited the unique and comprehensive capabilities of drug discovery from Takeda Pharmaceutical Company Limited: “Experienced Scientists”, “Cutting-edge Technology Platform”, and “Huge Historical Drug Discovery Data”, and started its business in 2017.
Axcelead offers the optimum solution in line with your research theme
Click here for detailsAxcelead offers fully integrated drug discovery services from target discovery to IND enabling translational research
Click Here for DetailsThe new modalities support epoch-making discovery research including breakthroughs in regenerative medicine, nucleic acids and peptide drug discovery
Click Here for DetailsOur highly experienced and expert staff will take care of your non-clinical development strategy and work to solve any problems
Click Here for DetailsHuman genome KI mice and rats is useful for the evaluation of new modality and small molecule in cases where efficacy has not been demonstrated on any other species.
DetailsAimed at bio-venture capitalists, academia, and companies planning to enter the pharmaceutical industry who wish to out-license
Click Here for DetailsResults of joint research with the University of Tokyo published in the international scientific journal “Nature Communications”
FRONTEO and Axcelead DDP Sign Master Collaboration Agreement for AI Drug Discovery Support Partnership
BIO-Europe: Meet us in Munich, Germany
HTS is a service to identify hit compounds with high probability in a short period of time.
We enable improvement of drug development efficiency and seamless translational research!
We offer an optimal package service for you to achieve your goal, such as IND application and out-licensing
Check out our latest scientific research, insights and passion for drug discovery.
We enjoy the patronage of more than 100 facilities, including pharmaceutical companies, startups and academic institutions